Login to Your Account



Novo study shows 8 percent weight loss with liraglutide

By Michael Fitzhugh
Staff Writer

Friday, May 16, 2014
Novo Nordisk A/S reported Friday that a 3-mg dose of liraglutide combined with a low-calorie diet and increased exercise helped obese non-diabetics achieve an 8 percent weight loss at 56 weeks, almost three times the 2.6 percent benefit realized by patients taking a placebo.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription